Alnylam Pharmaceuticals
ALNY
#535
Rank
โ‚ฌ38.10 B
Marketcap
288,45ย โ‚ฌ
Share price
0.78%
Change (1 day)
7.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company